在感染埃普斯坦-巴尔病毒的患者中调节T淋巴细胞子集的疗法:甘西克洛维尔与干扰素原子化吸入相结合
1Department of Pediatrics, Xingtai People's Hospital, Xiangdu District, Xingtai City, China.
甘西克洛维尔与干扰素原子化吸入相结合,有效调节艾普斯坦-巴尔病毒 (EBV) 感染患者的T淋巴细胞子集. 这种治疗改善了免疫状态,并显示出预测治疗结果的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 爱斯坦-巴尔病毒 (EBV) 感染与T淋巴细胞子集的显著变化有关.
- 了解抗病毒疗法对免疫细胞群的影响对于有效的治疗策略至关重要.
研究的目的:
- 评估甘西克洛维尔与干扰素原子化吸入组合在EBV感染患者T淋巴细胞子集上的疗效.
- 评估T淋巴细胞子集变化与治疗反应之间的相关性.
主要方法:
- 一项涉及50名EBV患者的研究,这些患者接受了甘西克洛维尔和干扰素治疗,与50名健康对照人进行了比较.
- 流细胞测量用于在治疗周期前后分析周围血液T淋巴细胞子集 (CD3+,CD4+,CD8+,CD4+/CD8+).
主要成果:
- 与对照组相比,EBV患者最初呈现的CD3+,CD4+和CD4+/CD8+水平较低,CD8+水平较高.
- 治疗导致CD3+,CD4+和CD4+/CD8+水平的逐渐改善和CD8+水平的下降,特别是在4个治疗周期后 (P < .05).
- 观察到的免疫调节表明积极的治疗效果没有显著的不良反应.
结论:
- 甘西克洛维尔和干扰素原子化吸入有效调节EBV感染中的T淋巴细胞子集.
- 在治疗期间监测T淋巴细胞亚群动态可以帮助预测EBV患者的治疗疗效.
更多相关视频
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
相关概念视频
Tumor Immunotherapy
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
